Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - fesoterodinum fúmarat - forðatafla - 8 mg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - fesoterodinum fúmarat - forðatafla - 4 mg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

evolan pharma ab - folic acid - tafla - 5 mg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - pemetrexedum dínatríum - stofn fyrir innrennslisþykkni, lausn - 500 mg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - pemetrexedum inn - innrennslisþykkni, lausn - 25 mg/ml

Европейский союз - исландский - EMA (European Medicines Agency)

pfizer europe ma eeig - lorlatinib - krabbamein, lungnakrabbamein - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

sanofi-aventis norge as - zolpidemum tartrat - filmuhúðuð tafla - 10 mg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - alprostadilum inn - stungulyfsstofn og leysir, lausn - 10 míkróg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - alprostadilum inn - stungulyfsstofn og leysir, lausn - 20 míkróg

Исландия - исландский - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - clidinii bromidum inn; chlordiazepoxidum inn - húðuð tafla